Skip to main content

Advertisement

SpringerLink
Log in

The Significance of Lateral Lymph Node Metastasis in Low Rectal Cancer: a Propensity Score Matching Study

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

The indications for lateral lymph node dissection (LLND) in rectal cancer have been controversial. The purpose of this study was to clarify the significance of lateral lymph node metastasis in low rectal cancer.

Methods

This was a retrospective study at a high-volume cancer center in Japan. In this study, 40 patients with pathologically positive LLN (LLN+) were matched with 175 negative (LLN−) patients by propensity score matching (PSM). COX regression analysis was used to identify independent risk factors related to prognosis. The relapse-free survival rate (RFS) and overall survival rate (OS) of the 2 groups before and after matching were analyzed.

Results

Of the 64 patients undergoing LLND, 40 (62.5%) patients had LLN+ disease. The LLN+ patients showed deeper infiltration of the primary tumor than the LLN− patients (T3-T4: 87.5% vs. 72.0%; p = 0.044), a greater number of metastatic lymph nodes (N2: 75.0% vs. 35.4%; p < 0.001), and a higher rate of local recurrence (30% vs. 9.1%; p < 0.001). Adjuvant chemotherapy was more common in the 40 LLN+ patients than in the 175 LLN− patients (70.0% vs. 46.8%; p = 0.008). After relapse, the rate of first-line chemotherapy administration for LLN+ patients was higher than that for the LLN− patients (62.5% vs. 29.5%; p = 0.005). The RFS of LLN+ patients was shorter than that of the LLN− patients (p = 0.005). After PSM, although more LLN+ patients received adjuvant chemotherapy than the LLN− patients (70.0% vs. 40.0%; p = 0.007), the local recurrence rate remained higher (30% vs. 10%; p = 0.025). The differences between RFS (p = 0.655) and OS rates (p = 0.164) of the 2 patient groups were not significant.

Conclusion

Even after LLND, patients with LLN+ low rectal cancer still showed an elevated local recurrence rate. Controlling local recurrence by adjuvant chemotherapy alone is difficult, and the additional strategic treatments are needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Shirouzu K, Ogata Y, Araki Y, Sasatomi T, Nozoe Y, Nakagawa M and Matono K: Total mesorectal excision, lateral lymphadenectomy and autonomic nerve preservation for lower rectal cancer: Significance in the long-term follow-up study. Kurume Med J 48(4): 307-319, 2001. DOI: https://doi.org/10.2739/kurumemedj.48.307

    Article  CAS  PubMed  Google Scholar 

  2. Moriya Y, Sugihara K, Akasu T and Fujita S: Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg 21(7): 728-732, 1997. DOI: https://doi.org/10.1007/s002689900298

    Article  CAS  PubMed  Google Scholar 

  3. Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K, Japanese Society for Cancer of the C and Rectum: Japanese society for cancer of the colon and rectum (jsccr) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1): 1-42, 2020. DOI: https://doi.org/10.1007/s10147-019-01485-z

    Article  PubMed  Google Scholar 

  4. Otero de Pablos J and Mayol J: Controversies in the management of lateral pelvic lymph nodes in patients with advanced rectal cancer: East or west? Front Surg 6(79, 2019. DOI: https://doi.org/10.3389/fsurg.2019.00079

    Article  PubMed  Google Scholar 

  5. Fujita S, Mizusawa J, Kanemitsu Y, Ito M, Kinugasa Y, Komori K, Ohue M, Ota M, Akazai Y, Shiozawa M, Yamaguchi T, Bandou H, Katsumata K, Murata K, Akagi Y, Takiguchi N, Saida Y, Nakamura K, Fukuda H, Akasu T, Moriya Y and Colorectal Cancer Study Group of Japan Clinical Oncology G: Mesorectal excision with or without lateral lymph node dissection for clinical stage ii/iii lower rectal cancer (jcog0212): A multicenter, randomized controlled, noninferiority trial. Ann Surg 266(2): 201-207, 2017. DOI: https://doi.org/10.1097/SLA.0000000000002212

    Article  PubMed  Google Scholar 

  6. Ozawa H, Kotake K, Hosaka M, Hirata A and Sugihara K: Impact of lateral pelvic lymph node dissection on the survival of patients with t3 and t4 low rectal cancer. World J Surg 40(6): 1492-1499, 2016. DOI: https://doi.org/10.1007/s00268-016-3444-y

    Article  PubMed  Google Scholar 

  7. Ueno H, Mochizuki H, Hashiguchi Y, Ishiguro M, Miyoshi M, Kajiwara Y, Sato T, Shimazaki H and Hase K: Potential prognostic benefit of lateral pelvic node dissection for rectal cancer located below the peritoneal reflection. Ann Surg 245(1): 80-87, 2007. DOI: https://doi.org/10.1097/01.sla.0000225359.72553.8c

    Article  PubMed  PubMed Central  Google Scholar 

  8. Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH and Mori T: Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg 246(5): 754-762, 2007. DOI: https://doi.org/10.1097/SLA.0b013e318070d587

    Article  PubMed  Google Scholar 

  9. Kinugasa T, Akagi Y and Shirouzu K: Benefit of lateral lymph node dissection for rectal cancer: Long-term analysis of 944 cases undergoing surgery at a single center (1975-2004). Anticancer Res 34(8): 4633-4639, 2014. http://www.ncbi.nlm.nih.gov/pubmed/25075111

    PubMed  Google Scholar 

  10. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K and Muto T: Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 49(11): 1663-1672, 2006. DOI: https://doi.org/10.1007/s10350-006-0714-z

    Article  PubMed  Google Scholar 

  11. Akiyoshi T, Ueno M, Matsueda K, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Unno T, Kano A, Kuroyanagi H, Oya M, Yamaguchi T, Watanabe T and Muto T: Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 21(1): 189-196, 2014. DOI: https://doi.org/10.1245/s10434-013-3216-y

    Article  PubMed  Google Scholar 

  12. Akiyoshi T, Toda S, Tominaga T, Oba K, Tomizawa K, Hanaoka Y, Nagasaki T, Konishi T, Matoba S, Fukunaga Y, Ueno M and Kuroyanagi H: Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo) radiotherapy in patients with advanced low rectal cancer. BJS Open 3(6): 822-829, 2019. DOI: https://doi.org/10.1002/bjs5.50194

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Akiyoshi T, Matsueda K, Hiratsuka M, Unno T, Nagata J, Nagasaki T, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y and Ueno M: Indications for lateral pelvic lymph node dissection based on magnetic resonance imaging before and after preoperative chemoradiotherapy in patients with advanced low-rectal cancer. Ann Surg Oncol 22 Suppl 3(S614-620, 2015. DOI: https://doi.org/10.1245/s10434-015-4565-5

    Article  PubMed  Google Scholar 

  14. Nakamura T and Watanabe M: Lateral lymph node dissection for lower rectal cancer. World J Surg 37(8): 1808-1813, 2013. DOI: https://doi.org/10.1007/s00268-013-2072-z

    Article  CAS  PubMed  Google Scholar 

  15. Oh HK, Kang SB, Lee SM, Lee SY, Ihn MH, Kim DW, Park JH, Kim YH, Lee KH, Kim JS, Kim JW, Kim JH, Chang TY, Park SC, Sohn DK, Oh JH, Park JW, Ryoo SB, Jeong SY and Park KJ: Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: A multicenter retrospective cohort study. Ann Surg Oncol 21(7): 2280-2287, 2014. DOI: https://doi.org/10.1245/s10434-014-3559-z

    Article  PubMed  Google Scholar 

  16. Inomata M, Shiroshita H, Uchida H, Bandoh T, Akira S, Yamaguchi S, Kurokawa Y, Seki Y, Eguchi S, Wada N, Takiguchi S, Ieiri S, Endo S, Iwazaki M, Sato Y, Tamaki Y, Kitamura K, Tabata M, Kanayama H, Mimata H, Hasegawa T, Takahashi H, Onishi K, Uemura T, Hashizume M, Matsumoto S, Kitano S and Watanabe M: Current status of endoscopic surgery in japan: The 14th national survey of endoscopic surgery by the japan society for endoscopic surgery. Asian J Endosc Surg 13(1): 7-18, 2020. DOI: https://doi.org/10.1111/ases.12768

    Article  PubMed  Google Scholar 

  17. Nonaka T, Fukuda A, Maekawa K, Nagayoshi S, Tokunaga T, Takatsuki M, Kitajima T, Taniguchi K and Fujioka H: Clinical and oncological outcomes of laparoscopic lateral pelvic lymph node dissection in advanced lower rectal cancer: Single-institution experience. Anticancer Res 37(9): 5095-5100, 2017. DOI: https://doi.org/10.21873/anticanres.11927

    Article  PubMed  Google Scholar 

  18. Mori T, Takahashi K and Yasuno M: Radical resection with autonomic nerve preservation and lymph node dissection techniques in lower rectal cancer surgery and its results: The impact of lateral lymph node dissection. Langenbecks Arch Surg 383(6): 409-415, 1998. DOI: https://doi.org/10.1007/s004230050153

    Article  CAS  PubMed  Google Scholar 

  19. Fujita S, Yamamoto S, Akasu T and Moriya Y: Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer. Int J Colorectal Dis 24(9): 1085-1090, 2009. DOI: https://doi.org/10.1007/s00384-009-0704-4

    Article  PubMed  Google Scholar 

  20. Ueno M, Oya M, Azekura K, Yamaguchi T and Muto T: Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 92(6): 756-763, 2005. DOI: https://doi.org/10.1002/bjs.4975

    Article  CAS  PubMed  Google Scholar 

  21. Ueno H, Mochizuki H, Hashiguchi Y and Hase K: Prognostic determinants of patients with lateral nodal involvement by rectal cancer. Ann Surg 234(2): 190-197, 2001. DOI: https://doi.org/10.1097/00000658-200108000-00008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Our thanks are extended to BioMed Proofreading, LLC for English copyediting.

Author information

Authors and Affiliations

  1. Division of Gastroenterological Surgery, Saitama Medical University International Medical Center, Hidaka, Saitama, Japan

    Liming Wang, Yasumitsu Hirano, Gregory Heng, Toshimasa Ishii, Hiroka Kondo, Kiyoka Hara, Nao Obara, Masahiro Asari & Shigeki Yamaguchi

Authors
  1. Liming Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasumitsu Hirano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gregory Heng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshimasa Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hiroka Kondo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kiyoka Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nao Obara
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Masahiro Asari
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shigeki Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

LMW and YH drafted the manuscript. TI, HK, KH, NO, MA, GH, and SY reviewed its content. All authors have read and approved the final submission.

Corresponding author

Correspondence to Liming Wang.

Ethics declarations

Disclosure of Interest

None to disclose

Consent for Publication

All patients have agreed to use their medical data for research and publication.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, L., Hirano, Y., Heng, G. et al. The Significance of Lateral Lymph Node Metastasis in Low Rectal Cancer: a Propensity Score Matching Study. J Gastrointest Surg 25, 1866–1874 (2021). https://doi.org/10.1007/s11605-020-04825-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-020-04825-x

Keywords

Search

Navigation